The next focusIR Investor Webinar takes places on 14th May with guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMarstons Regulatory News (MARS)

Share Price Information for Marstons (MARS)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 32.85
Bid: 32.85
Ask: 33.05
Change: 2.50 (8.24%)
Spread: 0.20 (0.609%)
Open: 30.90
High: 33.80
Low: 30.65
Prev. Close: 30.35
MARS Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Director/PDMR Shareholding

6 Mar 2024 08:35

RNS Number : 7976F
Marston's PLC
06 March 2024

This announcement replaces RNS 6993F released on 05-03-2024 at 16:24 due to an amendment.

6 March 2024

Notification of interests of directors and persons discharging managerial responsibilities

Marston's PLC (the "Company") announces that on 4 March 2024 the Directors listed below were granted awards over ordinary shares in the Company under the Company's Long Term Incentive Plan (the "Plan").

The number of shares over which awards were granted was calculated using the market price at the close of trading on the London Stock Exchange on 4 March 2024, being £0.2925 per ordinary share, save for the award granted to Hayleigh Lupino, where a notional share price of 33p was used to reflect the Remuneration Committee's decision to grant her an award over shares worth 125% of her base salary when the share price was 33p (which has decreased since that decision).

Awards under the Plan comprise two elements:

(i) a nil-cost option (a "Nil-Cost Option"), and

(ii) a CSOP Option over shares with a total value at the date of grant of £60,000 (the statutory limit) with an exercise price of £0.2925 per share (a "CSOP Option").

Performance Metrics

Nil-Cost Options will vest to the extent performance conditions are satisfied as set out below:

Measure

Weighting

Threshold (25% vest)

Maximum (100% vest)

Underlying PBT in 20261

20%

£75m

£95m

Net cash flow2 (2024, 2025 and 2026 aggregate)

40%

£150m

£180m

Operating Margin in 2026

20%

16.3%

18.3%

Relative Total Shareholder Return (TSR) (measured over FY2023/24 to FY2025/2026)

20%

Median

Upper quartile

1. Underlying PBT: exclusive of income from associates.

2. Net cash inflow/(outflow) as per the Net Debt note to the financial statements.

3. Straight-line vesting applies between Threshold and Maximum.

To the extent the performance metrics are met, a Nil-Cost Option will be released following the end of a further two-year holding period.

Linking Arrangement between Nil-Cost Option and CSOP Option

The options have been granted such that the maximum pre-tax value delivered to the participant will not exceed the value of the shares over which the Nil-Cost Option would have vested if it was a standalone option.

The CSOP option will be released only to the extent that the aggregate CSOP gain is less than or equal to the value of the shares over which the Nil-Cost Option would be released on the normal release date.

Name

Designation

Number of shares subject to CSOP Option

Number of shares subject to Nil-Cost Option

Justin Platt

Director

205,128

2,871,795

Hayleigh Lupino

Director

205,128

1,347,041

Enquiries:

Bethan Raybould, General Counsel & Company Secretary, Marston's PLC, +44 (0) 1902 907250

Notification of Dealing Form

1.

Details of the Person Discharging Managerial Responsibility ("PDMR")/person closely associated with them ("PCA")

a)

Name

Justin Platt

2.

Reason for the notification

a)

Position/status

Director and PDMR (Chief Executive Officer)

b)

Initial notification/ amendment

Initial Notification

3.

Details of the Issuer

a)

Name

Marston's PLC

b)

LEI code

213800Q6RP3ZJ2CZR962

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument

Identification code

Ordinary Shares of 7.375 pence each

ISIN: GB00B1JQDM80

b)

Nature of the transaction

Grant of awards under the Marston's PLC Long Term Incentive Plan in the form of a CSOP option with an exercise price of £0.2925 per share and a nil-cost option.

c)

Price(s) and volumes(s)

Price

Volume

Nil-cost option: N/A

2,871,795

CSOP option: £0.2925

205,128

d)

Aggregated information

- Aggregate volume

- Price

N/A

e)

Date of the transaction

2024-03-04

f)

Place of the transaction

Outside a trading venue

1.

Details of the Person Discharging Managerial Responsibility ("PDMR")/person closely associated with them ("PCA")

a)

Name

Hayleigh Lupino

2.

Reason for the notification

a)

Position/status

Director and PDMR (Chief Financial Officer)

b)

Initial notification/

amendment

Initial Notification

3.

Details of the Issuer

a)

Name

Marston's PLC

b)

LEI code

213800Q6RP3ZJ2CZR962

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument

Identification code

Ordinary Shares of 7.375 pence each

ISIN: GB00B1JQDM80

b)

Nature of the transaction

Grant of awards under the Marston's PLC Long Term Incentive Plan in the form of a CSOP option with an exercise price of £0.2925 per share and a nil-cost option.

c)

Price(s) and volumes(s)

Price

Volume

Nil-cost option: N/A

1,347,041

CSOP option: £0.2925

205,128

d)

Aggregated information

- Aggregate volume

- Price

N/A

e)

Date of the transaction

2024-03-04

f)

Place of the transaction

Outside a trading venue

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
DSHEAPDKEDLLEEA
Date   Source Headline
2nd Jul 20182:48 pmRNSTotal Voting Rights
2nd Jul 20189:27 amRNSDirector/PDMR Shareholding
21st Jun 20189:57 amRNSHolding(s) in Company
19th Jun 20183:21 pmRNSDirector/PDMR Shareholding
19th Jun 201811:07 amRNSHolding(s) in Company
12th Jun 201810:13 amRNSDirector/PDMR Shareholding
6th Jun 20181:18 pmRNSDirector/PDMR Shareholding
5th Jun 20187:00 amRNSStatement re analyst site visit
23rd May 201812:09 pmRNSDirector/PDMR Shareholding
16th May 20187:00 amRNSInterim Results for 26 weeks ended 31 March 2018
11th May 201812:38 pmRNSAppointment of Interim Chairman
16th Apr 20189:51 amRNSHolding(s) in Company
3rd Apr 201811:01 amRNSTotal Voting Rights
15th Mar 20187:00 amRNSDirectorate Change
15th Mar 20187:00 amRNSAppointment of Chairman
21st Feb 20184:01 pmRNSHolding(s) in Company
6th Feb 20182:12 pmRNSDirector/PDMR Shareholding
24th Jan 20189:53 amRNSResult of AGM
23rd Jan 20187:00 amRNSTrading update for the 16 weeks to 20 January 2018
10th Jan 201810:07 amRNSBlock listing Interim Review
2nd Jan 20183:54 pmRNSDirector/PDMR Shareholding
2nd Jan 20182:25 pmRNSTotal Voting Rights
20th Dec 20179:42 amRNSDirector Declaration
20th Dec 20177:00 amRNSWilliam Hill appoints Chairman Designate
18th Dec 20174:27 pmRNSAnnual Financial Report
12th Dec 20174:27 pmRNSDirector/PDMR Shareholding
12th Dec 20174:25 pmRNSDirector/PDMR Shareholding
5th Dec 20172:02 pmRNSDirector/PDMR Shareholding
1st Dec 201711:44 amRNSTotal Voting Rights
30th Nov 20177:00 amRNSPreliminary Results
27th Nov 20177:00 amRNSDirectorate
1st Nov 20171:17 pmRNSTotal Voting Rights
10th Oct 20177:00 amRNSYear-End Trading Update
2nd Oct 20172:48 pmRNSTotal Voting Rights
29th Sep 201710:27 amRNSDirector/PDMR Shareholding
8th Sep 20172:20 pmRNSDirector/PDMR Shareholding
5th Sep 201711:55 amRNSDirectorate Change
1st Sep 20171:47 pmRNSTotal Voting Rights
26th Jul 20177:00 amRNSTrading Update
11th Jul 20178:41 amRNSBlock listing Interim Review
5th Jul 20174:18 pmRNSDirector/PDMR Shareholding
4th Jul 20179:04 amRNSDirector/PDMR Shareholding
28th Jun 20174:03 pmRNSDirector/PDMR Shareholding
22nd Jun 20173:06 pmRNSDirector/PDMR Shareholding
20th Jun 20172:13 pmRNSDirector/PDMR Shareholding
20th Jun 20177:01 amRNSDirector Declaration
2nd Jun 20174:45 pmRNSCompletion of Acquisition of Charles Wells
25th May 20173:12 pmRNSHolding(s) in Company
22nd May 20173:19 pmRNSTotal Voting Rights
18th May 20172:42 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.